Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication Reduction

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 6, 2021

Primary Completion Date

February 27, 2023

Study Completion Date

March 28, 2023

Conditions
Restless Legs Syndrome
Interventions
DEVICE

Noninvasive Peripheral Nerve Stimulation (NPNS)

NPNS device programmed to deliver active stimulation.

Trial Locations (2)

43017

Ohio Sleep Medicine Institute, Dublin

90241

Mark J Buchfuhrer private practice, Downey

Sponsors
All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Noctrix Health, Inc.

INDUSTRY

NCT04698343 - Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication Reduction | Biotech Hunter | Biotech Hunter